In this review we have attempted to present an up-to-date account of work in the field of "histaminology" related to human blood that is concerned both with methods for the determination of the amine and with studies of its distribution between the formed elements and plasma. Our own interests have influenced the choice of topics and we have included sections on blood histamine in asthma and in the newborn infant. Another section deals with the still very controversial topic of histaminopexy.
We gladly acknowledge the help afforded to us by earlier reviews, especially those by Code (28), Lindell and Westling (76), and Parrot et al. (103, 104) .
Since the early 1930's workers have been determining the histamine levels in blood and studying the distribution of histamine between the various cells and plasma. Despite this, Lindell and Westling wrote in 1966 (76) that the confusion concerning blood histamine is greater than in any other area of histamine research. In blood, the largest amount of histamine is found in the cells. As early as 1937, Code (27) considered that strong evidence existed for the assumption that 361 the majority of histamine in human blood is localized in the leukocytes. Later it was concluded that most of the histamine in the blood of healthy humans is associated with the basophil and eosinophil leukocytes [Graham et al. (52, 53) , Code and Mitchell (29)] . At the present time the basophils, like their tissue equivalents, the mast cells, are believed to be important storage sites for histamine; however, no clear role has yet been cast for the eosinophils.
The localization of histamine principally in the basophilic leukocytes allows the number of basophils in the blood to be used as an index of the amount of histamine present. Whole-blood histamine levels give little or no positive evidence for the involvement of histamine in the pathogenesis of various diseases. In myelogenous leukemia, for example, although the histamine levels in whole blood are increased to upward of 500 times normal values [Shimkin et al. (130) Since 60 % of histamine hydrochloride, but only 36 % of the acid phosphate, is equivalent to the free base, the reported values may differ widely depending on the reference used; if this is not stated, the values obtained are ambiguous and comparisons cannot be made. Because the free base is the pharmacologically active portion of the molecule it is therefore the most satisfactory reference [Code (28) ]. Throughout this review histamine values are reported as the free base unless stated otherwise. The concentration of histamine in rabbit blood is the highest in any species so far reportedin the region of l-5 pg/ml [Rose and Weil (123) , Code (27) ]. At the other end of the scale are dogs and cats; the values for dogs range from 0 to 40 rig/ml [Barsoum and Gaddum (9) ]. V a ues for man lie between these extremes, 1 and there is far less histamine in human than in rabbit blood. only from histidine concentrations 100-500 times stronger than those found in blood and plasma, and even then they found that the histamine formation was minimal if the HCl digestion was not too vigorous.
In 1961 Adam (1) modified the earlier method (2, 3) for the estimation of histamine in plasma by the inclusion of an HCl digestion stage after elution resin columns. This is a gentle digestion procedure carried out in a paraffin fror n bath has enabled the method to be applied to brain tissue, which heated to 100 C; it contains high levels In our own s tudies we have used histamine in whole blood (which of pharmacologically active bases other than histamine (1 (129) reported a study of blood histamine levels during asthmatic attacks over a period of some hours from the onset of the asthmatic symptoms, blood samples being withdrawn from the patients at fixed time intervals. Using this procedure he found an initial rise in blood histamine at the onset of the attack, quickly followed by a drop to below normal values. Rose and his colleagues (122) found no increase in blood histamine during the provoking of an "asthmalike" state, but found the blood histamine values generally to be higher in asthmatic subjects than in normals. Maas et al. (78) 2) asthma syrnptoms group; and 3) a group of children on long-term steroid therapy. Lindell and Westling (76) commented that what is certain about allergic subjects is that their histamine metabolism and their reaction to histamine are different from the norm. It is also known that asthmatics tend to have "pathological" blood histamine levels, i.e., outside of the range 20-100 rig/ml. Lindell and Westling (76) concluded that, although blood histamine levels are often observed to rise during attacks, it cannot therefore be assumed that this histamine is released directly during an attack and that this rise in blood histamine only suggests a connection between histamine and asthma. Few measurements of histamine in the blood plasma of asthmatic people have been published.
Beall (1 1), using the spectrophotofluorimetric method of Noah and Brand (95), f ound no significant difference between normal plasma histamine levels and those of asthmatic and allergic subjects. The mean plasma histamine concentration of a group of normal subjects was determined as 5.6 rig/ml and this value was found to be unchanged in the asthmatic patients studied. Porter and Mitchell (107), using the methods of Adam and his colleagues (3), found less than 1 rig/ml in all the asthmatic children they studied in each of their three groups (a total of 55 children), which is also in agreement with the values for normal adults and children (3, 106). Basophil leukocytes in asthma and allergy were first studied by Cannon in 1892 (25), who reported a slight percentage increase in the basophil count in asthmatic blood. In 1957 Noah and Brand (94) counted basophils in three asthmatic patients and found normal values. Criticisms leveled at their work concern the small number of subjects studied and the method of counting used (the count being performed on 1000 leukocytes). Rorsman (117) used a slightly modified version of the method of Moore and ,James (93) on blood from 20 asthmatic subjects and was not able to observe a significant increase in the blood basophil count. Rorsman drew attention to the fact that a large proportion of the patients under study were being treated with epinephrine or corticosteroids; corticosteroids are known to produce a lowering of the blood basophil count [Code et al. (30) ]. Rorsman (117) postulated that were an increased basophil count seen in untreated asthmatics, this could be a possible explanation for the increased histamine content reported by many workers.
This increased histamine content was also recorded by Porter and Mitchell (107) in their group of children with asthmatic symptoms. They found a mean of 81 rig/ml (SEM 9.4) and this was significantly higher than the mean whole-blood histatnine level for the quiescent asthma group 57 rig/ml, SEM 5.6) and the longterm steroid therapy group (51 rig/ml, SEM 5.1). No significant difference was found between the mean whole-blood histamine level for their control group of children and the latter two asthmatic groups.
In a study of six asthmatic children Blau and Plenert (16) (29) further reported that the basophil and eosinophil counts were decreased by cortisone in dogs and guinea pigs as well as in man. In man and dog whole-blood histamine levels were also diminished but in guinea pigs this change was not constant. Noah and Brand (94) studied 11 patients mostly suffering from asthma and found marked falls in leukocytes and blood histamine levels in those given therapeutic doses of prednisone.
They also reported that the fluctuations in blood histamine levels paralleled more closely the fluctuations in basophil counts than those of any other type of cell. Using a relatively insensitive procedure they found no significant change in plasma histamine values after steroid administration. Porter and Mitchell (107) obtained similar findings with a group of asthmatic children on long-term steroid therapy. Porter et al. (109) studied a group of children on short-term steroid therapy for periods between 5 min and 2.5 hr after administration of a single dose of corticosteroid, and at none of these times did the children deinonstratc a rise in the plasma histamine level. In work on guinea pigs Kovacs and Suffiad (71) The compound is neither a bronchodilator nor antiinflammatory and its action is distinct from that of the corticosteroids.
Cox (34) added that disodium cromoglycate has few general pharmacological actions, is rapidly excreted from the body, and appears to have a very low order of toxicity. He concluded that the ability of the compound to inhibit the anaphylactic process initiated by the reaginic antibody-antigen interaction may permit a more specific treatment of akrgic disease, especially of the lung.
Later an annotation in Lancet (5) expressed an interest in the compound, but drew attention to the fact that the preparation used was a mixture of disodium cromoglycate 20 mg, isoprenaline sulfate 0.1 mg, and lactose. Clinical trials have indicated, however, that the combination of cromoglycate and isoprenaline produces significant improvement when compared with isoprenaline and lactose alone in patients with allergic asthma but not in nonallergic cases [Howell and Altounyan (59) ]. Though it is obvious that cromoglycate may have measurable effects on the distribution of histamine in the body, no reports of its effects on blood histamine levels and granulocyte counts have appeared in the literature up to this time.
HISTAMINOI'E XY
In 1952 Parrot, Urquia, and Laborde (105) described the binding of histamine by serum. They found that when a solution containing histamine dihydrochloride (1 pg/ml) and 5 % normal human serum, previously dialyzed for 24 hr, was tested for biological activity on the isolated guinea pig ileum the effect of the histamine was reduced by approximately 30 Yo. This phenomenon was termed "histamino- to be the binding of histamine and not its enzymic destruction, since it was possible to recover the activity by addition of a binding competitor or even by simple dilution (104). Various techniques have been devised for the estimation of serum histaminepexy : one of the most convenient is the pharmacological method mentioned above; this method was used in our own studies. With the use of a manually operated organ bath, the method described by Laborde et al. (74) Ruitton et al. (124) . I n an Australian study using a seroagglutination technique Freeman (47) reported that in 3 15 cases allergic sera gave 82 70 negative results and in 88 control sera 66 c/o gave positive agglutination.
It has been shown that the serum of normal subjects binds histamine (loo), Shydroxytryptamine (99), and acetylcholine (45). In all their large-scale investigations Parrot and his colleagues have studied histamine binding using the pharmacological technique.
A group of 79 subjects without allergic symptoms and without familial allergy all showed histaminopexy.
Later, when a group of 225 subjects who were not so carefully selected was studied, low values were found in 7 c/a of the subjects (102). Parrot and colleagues (104) claimed that histaminopexy values equal to or greater than 15 % could be regarded as normal.
Normal serum histaminopexy has been attributed to the presence of a gamma globulin-plasmapexin I [Laborde et al. (73)]. Th is material represents only 0.01 %: of all the globulins present in serum, but these workers argue that it is adequate to produce the serum histaminopexic action. This fraction is also believed to bind 5-hydroxytryptamine and acetylcholine (45, 99 He concluded that further purification of the binding factor was required before a conclusion as to its identity could be reached. Freeman (48), in studies using immunoelectrophoresis, reported that the identity of one of the fractions showing histaminopexic activity (that precipitated with 0.8 M ANa2S04) was IgG. The active fraction was also precipitated in vitro by specific anti-IgG serum, and after removal of the precipitate the histaminopexy using the latex test was negative. However, she found in addition that some sera also precipitated their active fraction with 0.96 M Na2S04 and that these fractions contained traces of alpha globulins. It has been shown that the allergic subject's serum does not bind histamine, 5hydroxytryptamine, or acetylcholine (45, 99). Parrot and colleagues (104) wrote that lack of histaminopexy had sometimes been noted in the course of systematic investigations, even when the subject showed no clinical signs of allergy; however, in some of these subjects asthmatic attacks did occur subsequently.
From this they (104) concluded that the loss of histaminopexy is likely to precede the clinical symptoms. Parrot and Laborde (102) examined a group of 74 patients with asthma and hayfever. In 97 % of the subjects histaminopexy was absent. In the same study, all of a group of 14 patients with urticaria and angioneurotic edema had zero histaminopexy.
Porter and Smith (108) carried out histaminopexy determinations in a group of control children, a group of children with asthmatic symptoms, and a group of quiescent asthmatic children. They found a mean histaminopexy of 18 % in the control group, 17 % in the quiescent asthmatic group, and 12 % in the group of children with asthmatic symptoms. When the Student t test was applied to the means the difference between the group of control children and that of children with asthmatic symptoms was significant at the 5 % level. However, no significant difference was found between the means for the control children and the children with quiescent asthma. The authors suggested that one of the reasons why their results were not as decisive as those of other workers was because asthma may not always be a purely allergic phenomenon.
If attacks are consistently precipitated only by an antigen-antibody reaction the condition is clearly allergic, but when symptoms can be provoked by physical or emotional stimuli the etiology may be more complex. Laborde et al. (73) claimed that there is no plasmapexin I in allergic serum. They did find, however, an antipexin that is an alpha or beta globulin and inhibits the binding of histamine by plasmapexin I. Together with this they found plasmapexin II, which is a gamma globulin able to bind histamine, but exerting no action in the serum. Several workers measuring the levels of histamine in the blood of women before and after delivery have found that pregnant women have normal or slightly lowered blood histamine levels when studied some weeks before delivery. Effkemann and Werle (38) reported whole-blood histamine levels of 30-45 rig/ml in the 7th and 8th months of pregnancy.
However, at delivery these values seem to be decreased;
BjurG and his colleagues (14) reported whole-blood histamine levels of 6-18 rig/ml at delivery. This lowered histamine level is probably due to the presence of the enzyme diamine oxidase (histaminase). The levels of this enzyme in the blood are very much increased in pregnant women [Ahlmark (4)]. Mitchell and Cass (90) f ound slightly elevated levels in blood from the umbilical vein at birth (1 case in 10 was above 100 rig/ml). Bjurij et al. (14) quoted values for blood from both the umbilical vein and artery. Those for the umbilical vein were 33-l 25 rig/ml and for the artery 40-l 35 rig/ml, which is a difference of approximately 15 % between the arterial and venous levels. Whole-blood histamine levels in newborn infants thus appear to be 2-5 times higher than those of the mothers at delivery (14). Dieckhoff and Cobet (37) also carried out a study of the blood histamine levels in the newborn.
In a group of 11 newborn infants at term the whole-blood histamine levels were in the ranges 15-67 ng/rnl arterial and 5-37 rig/ml venous. Again a tendency to higher levels was seen in the arterial blood. In a group of 9 premature newborn infants the histamine levels in the umbilical cord blood were lo-33 rig/ml arterial and lo-26 rig/ml venous. Here no significant differences were observed between the arterial and venous ranges. In normal term and preterm infants we have found whole-blood histamine levels similar to those in healthy adults and no significant difference between the mean values in umbilical arterial and venous blood [Mitchell and Porter (9 l) ]. In 10 distressed newborn infants the mean values for histamine in both arterial and venous umbilical cord blood were slightly higher than normal, but the difference was not significant (110 
